Is CD47 an innate immune checkpoint for tumor evasion? X Liu, H Kwon, Z Li, Y Fu Journal of Hematology & Oncology 10, 1-7, 2017 | 200 | 2017 |
Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer H Kwon, JM Schafer, NJ Song, S Kaneko, A Li, T Xiao, A Ma, C Allen, ... Science immunology 7 (73), eabq2630, 2022 | 109 | 2022 |
The Diaphanous-Related Formins Promote Protrusion Formation and Cell-to-Cell Spread of Listeria monocytogenes R Fattouh, H Kwon, MA Czuczman, JW Copeland, L Pelletier, ME Quinlan, ... The Journal of infectious diseases 211 (7), 1185-1195, 2015 | 58 | 2015 |
GARP dampens cancer immunity by sustaining function and accumulation of regulatory T cells in the colon M Salem, C Wallace, M Velegraki, A Li, E Ansa-Addo, A Metelli, H Kwon, ... Cancer research 79 (6), 1178-1190, 2019 | 57 | 2019 |
Multiple Host Kinases Contribute to Akt Activation during Salmonella Infection B Roppenser, H Kwon, V Canadien, R Xu, PN Devreotes, S Grinstein, ... PloS one 8 (8), e71015, 2013 | 26 | 2013 |
Sex differences in using systemic inflammatory markers to prognosticate patients with head and neck squamous cell carcinoma CY Lin, H Kwon, GO Rangel Rivera, X Li, D Chung, Z Li Cancer Epidemiology, Biomarkers & Prevention 27 (10), 1176-1185, 2018 | 22 | 2018 |
Sex-biased adaptive immune regulation in cancer development and therapy JM Schafer, T Xiao, H Kwon, K Collier, Y Chang, H Abdel-Hafiz, C Bolyard, ... Iscience 25 (8), 2022 | 18 | 2022 |
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity A Li, Y Chang, NJ Song, X Wu, D Chung, BP Riesenberg, M Velegraki, ... Journal for Immunotherapy of Cancer 10 (9), 2022 | 14 | 2022 |
Decoding the glycoproteome: a new frontier for biomarker discovery in cancer K He, M Baniasad, H Kwon, T Caval, G Xu, C Lebrilla, DW Hommes, ... Journal of Hematology & Oncology 17 (1), 12, 2024 | 7 | 2024 |
Sex as a predictor of response to cancer immunotherapy H Kwon, CY Lin, D Chung, X Li, Z Li The Lancet Oncology 19 (8), e379, 2018 | 7 | 2018 |
Sex-biased adaptive immune regulation in cancer development and therapy. iScience 25, 104717 JM Schafer, T Xiao, H Kwon, K Collier, Y Chang, H Abdel-Hafiz, C Bolyard, ... | 5 | 2022 |
Association of myeloid suppressor cells with resistance to checkpoint blockade immunotherapy in urothelial carcinoma. D Sundi, MC Duggan, H Savardekar, H Kwon, S Sun, B Benner, ... Journal of Clinical Oncology 38 (6_suppl), 559-559, 2020 | 1 | 2020 |
Eosinophil-neutrophil ratio as a sex-dependent prognostic marker in immune checkpoint therapy for metastatic NSCLC and transcriptomic evaluation of intratumoral eosinophil-T … H Kwon, M Li, A Ma, C Wang, K Chian, T Gauntner, N Jones, ... Journal of Clinical Oncology 42 (16_suppl), 8586-8586, 2024 | | 2024 |
Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy L Zhou, M Velegraki, Y Wang, JK Mandula, Y Chang, W Liu, NJ Song, ... The Journal of Clinical Investigation, 2024 | | 2024 |
Case report: Hypereosinophilia in non-small cell lung cancer H Kwon, M Li, JD Sheldon, N Jones, NG Crestani, Z Li, DH Owen Current Problems in Cancer: Case Reports 13, 100275, 2024 | | 2024 |
P1. 21-15 Prognostic Value of Change in Platelet Volume for Patients with Metastatic Non-small Cell Lung Cancer Treated with Pembrolizumab M Li, S Zhao, K Chian, K Chakravarthy, H Kwon, T Gauntner, N Jones, ... Journal of Thoracic Oncology 18 (11), S240-S241, 2023 | | 2023 |
Patterns of weight change and overall survival (OS) during first-line pembrolizumab treatment in patients with non-small cell lung cancer (NSCLC). M Li, S Zhao, K Chian, H Kwon, N Jones, A Khorasanchi, T Gauntner, ... Journal of Clinical Oncology 41 (16_suppl), e21094-e21094, 2023 | | 2023 |
Sex differences in prognostic utility of peripheral eosinophil count in first-line immune checkpoint therapy against metastatic NSCLC. H Kwon, M Li, K Chian, T Gauntner, N Jones, A Khorasanchi, ... Journal of Clinical Oncology 41 (16_suppl), 9067-9067, 2023 | | 2023 |
Sorafenib-Induced Capillary Leak Syndrome H Kwon, J Odackal, M Husain, DA Liebner Case Reports in Oncology 16 (1), 1087-1094, 2023 | | 2023 |
839 Selective targeting of GARP-LTGFß Axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell anti-tumor immunity A Li, Y Chang, NJ Song, X Wu, D Chung, B Riesenberg, M Velegraki, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |